On Sunday, the Miami Dolphins fell to 0-4 with a 15-10 loss against the Minnesota Vikings.It marks the first time the team has started 0-4 since the 2019 season when the team went winless after seven games.The Dolphins are one of five NFL teams that have not won a game. The Los Angeles Chargers are…
The San Francisco 49ers beat the Denver Broncos 24-14 on Sunday to remain undefeated and improve to 4-0.Despite holding the Broncos to 14 points and 296 yards of offense, the 49ers’ defense did not record a sack or tackle for loss.However, the 49ers are hopeful to get a big boost to their defensive…
Walker Buehler has spent the season being one of the San Diego Padres' most valuable starting pitchers. That might not be immediately apparent from the overlying statistics, but the metrics under the surface show a different picture. San Diego will be all hands on deck after dropping both games to…
OCALA, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media coverage of the antiviral potential of Ampligen ® (rintatolimod), the Company’s investigational dsRNA and highly selective TLR3 agonist immunomodulator.
The Los Angeles Dodgers are tied 1-1 with the Atlanta Braves in the NLDS. Still, with the offseason approaching, it’s worth considering which players on their roster could potentially draw interest from teams looking to make a move.Matt Postins of the Texas Rangers on SI floated Dodgers outfielder…
Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, compared to the daily subcutaneous injections required by the current standard of care
A researcher at a lab in Siberia has died after potentially being exposed to pneumonic plague, according to reports. Now, almost 200 people are reportedly under quarantine in the wake of that death, with the incident putting health officials around the world on alert. NBC’s Daniele Hamamdjian…
- In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versus 40% in the placebo arm (p=0.0248); HS troponin I, a blood marker of heart muscle injury, declined…